18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus–Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified …

RM Subramaniam, L DeMora, M Yao… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The purpose of this study was to determine the negative predictive value (NPV) of a 12-to 14-
wk posttreatment PET/CT for 2-y progression-free survival (PFS) and locoregional control …

18 FDG PET/CT prediction of treatment outcomes in patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer (LA-OPC) …

RM Subramaniam, L Demora, M Yao, SS Yom… - 2020 - ascopubs.org
6563 Background: To determine the negative predictive value (NPV) of 12-14 week post-
treatment PET/CT for 2-year progression-free survival (PFS) and 2-year locoregional control …

Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer

JM Vainshtein, ME Spector, MH Stenmark, CR Bradford… - Oral oncology, 2014 - Elsevier
Objectives Although widely adopted, the accuracy of post-chemoradiotherapy (CRT) 18 F-
fluorodeoxygluocose positron emission tomography/computed tomography (PET/CT) for …

Initial Feasibility and Acute Toxicity Outcomes from a Phase II trial of FDG-PET response-based de-escalated definitive chemoradiotherapy for p16+ oropharynx …

SG Allen, BS Rosen, M Aryal, Y Cao… - … Journal of Radiation …, 2023 - europepmc.org
Purpose 18 F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) parameters
are prognostic of oncologic outcomes in human papillomavirus-associated oropharyngeal …

Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of 18F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated …

SG Allen, BS Rosen, M Aryal, Y Cao… - International Journal of …, 2023 - Elsevier
Purpose 18 F-Fluorodeoxyglucose positron emission tomography (FDG-PET) parameters
are prognostic of oncologic outcomes in human papillomavirus–associated oropharyngeal …

CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy

BS Rosen, JR Wilkie, Y Sun, M Ibrahim… - Radiotherapy and …, 2021 - Elsevier
Purpose To assess associations between imaging biomarkers from standard of care pre-
treatment CT and FDG-PET scans and locoregional (LR) and distant metastatic (DM) …

The prognostic value of baseline 18F-FDG PET/CT in human papillomavirus–positive versus human papillomavirus–negative patients with oropharyngeal cancer

ZAR Gouw, MD La Fontaine, S van Kranen… - Clinical nuclear …, 2019 - journals.lww.com
Purpose Oropharynx cancer (OPC) is heterogeneous; human papillomavirus (HPV)–positive
and HPV− tumors represent 2 disease entities with a different prognosis. Earlier studies …

Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo) radiotherapy

HY Liu, R Milne, G Lock, BJ Panizza, A Bernard… - Oral Oncology, 2019 - Elsevier
Objectives To assess the utility of a repeat positron emission tomography/computed
tomography (PET/CT) instead of immediate neck dissection (ND) for incomplete nodal …

Early 18F-FDG-PET response during radiation therapy for HPV-related oropharyngeal cancer may predict disease recurrence

YM Mowery, I Vergalasova, CN Rushing… - International Journal of …, 2020 - Elsevier
Purpose Early indication of treatment outcome may guide therapeutic de-escalation
strategies in patients with human papillomavirus (HPV)-related oropharyngeal cancer …

18F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma

T Bird, S Barrington, S Thavaraj, JP Jeannon… - European journal of …, 2016 - Springer
Purpose To evaluate the use of 18 F-FDG PET/CT as the principal investigation to assess
tumour response, to determine the need for further surgery and to guide follow-up following …